DISCONTINUED OPERATIONS - Schedule of Loss from Discontinued Operations, Net of Tax (Details) - Discontinued Operations, Disposed of by Sale - RX Pharmaceuticals - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Administration	$ 13.0	$ 10.4	$ 4.6
Loss from discontinued operations before tax	(13.0)	(10.4)	(4.6)
Income tax (benefit) expense	(1.9)	(2.1)	5.1
Loss from discontinued operations, net of tax	$ (11.1)	$ (8.3)	$ (9.7)